Description: Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. The company offers active pharmaceutical ingredients (APIs) and formulations for use in various therapeutic areas, including anti-tuberculosis, anti-malarials, cardiology, pain management, anti-infectives, haematinics, health and nutrition, anaesthesia, gynecology, and orthopedics. It also offers anti-inflammatory drugs and other drugs. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001. Themis Medicare Limited was founded in 1952 and is headquartered in Mumbai, India.
Home Page: www.themismedicare.com
11/12 Udyog Nagar Industrial Estate
Mumbai,
400104
India
Phone:
91 22 6760 7080
Officers
Name | Title |
---|---|
Dr. Dinesh Shantilal Patel CChem., FRSC(Lond.), Ph.D. | Executive Chairman |
Dr. Sachin Dinesh Patel CChem., Ph.D. | CEO, MD & Executive Director |
Ms. Reena Sachin Patel | VP of Systems & Administration and Alternate Non-Executive Non-Independent Director |
Mr. Tushar J. Dalal A.C.A. | Chief Financial Officer |
Exchange: NSE
Country: IN : India
Currency: Indian Rupee (INR)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Pharmaceuticals |
GIC Sub-Industry: | Pharmaceuticals |
Forward PE: | 0 |
---|---|
Trailing PE: | 51.054 |
Price-to-Book MRQ: | 6.5464 |
Price-to-Sales TTM: | 6.4213 |
IPO Date: | |
Fiscal Year End: | March |
Full Time Employees: | 1509 |